Publication | Open Access
Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer
108
Citations
32
References
2011
Year
Gene expression appears to identify KRAS wt mCRC patients who receive little benefit from cetuximab. It will be important to test this model in an independent validation study.
| Year | Citations | |
|---|---|---|
Page 1
Page 1